Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | SELE | P16581 | 4/20 | 0.35 |
| ▸ | VCAM1 | P19320 | 4/20 | 0.35 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13407339 | 0.92 | MAPK1 (0.33) | MAPK1HSD17B10SELEVCAM1ICAM1 | |
| SCHEMBL9980122 | 0.87 | MAPK1 (0.42) | MAPK1HSD17B10SELEVCAM1ICAM1 | |
| SCHEMBL13407338 | 0.85 | ICAM1 (0.32) | MAPK1HSD17B10SELEVCAM1ICAM1 | |
| SCHEMBL13407340 | 0.85 | ESR1 (0.35) | MAPK1HSD17B10SELEVCAM1ICAM1 | |
| SCHEMBL26816216 | 0.82 | HSD17B10 (0.33) | MAPK1HSD17B10ALDH1A1 | |
| SCHEMBL10144385 | 0.80 | PKM (0.39) | MAPK1HSD17B10SELEVCAM1GAA | |
| SCHEMBL15368418 | 0.80 | MAPK1 (0.34) | MAPK1HSD17B10SELEVCAM1ICAM1 | |
| SCHEMBL13407341 | 0.80 | ESR1 (0.39) | — | |
| SCHEMBL13032428 | 0.79 | CYP2A6 (0.45) | ALDH1A1CA2PKMNPSR1RXFP1 | |
| SCHEMBL119523 | 0.79 | ALDH1A1 (0.42) | MAPK1HSD17B10GAAALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827651-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-28 | — | — | US | disclosed |
| US-11827651-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-28 | — | — | US | disclosed |
| US-20200361975-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-19 | — | — | US | disclosed |
| EP-2621927-B1 | SEMICONDUCTORS BASED ON DIKETOPYRROLOPYRROLES | BASF SE (DE) | 2020-02-12 | — | — | EP | disclosed |
| EP-3024040-B1 | ORGANIC FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, AND ORGANIC SEMICONDUCTOR MATERIAL AND USE APPLICATIONS THEREOF | FUJIFILM CORP (JP) | 2019-05-08 | — | — | EP | disclosed |
| EP-3154988-B1 | BORYLATED COMPOUNDS | UNIV MANCHESTER (GB) | 2019-01-09 | — | — | EP | disclosed |
| US-20170200892-A1 | FIELD-EFFECT TRANSISTORS BASED ON MACROSCOPICALLY ORIENTED POLYMERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-07-13 | — | — | US | disclosed |
| EP-2892977-B9 | DIKETOPYRROLOPYROLE (DPP)-BASED SENSITIZERS FOR ELECTROCHEMICAL OR OPTOELECTRONIC DEVICES | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2017-05-03 | — | — | EP | disclosed |
| US-20170029408-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2017-02-02 | — | — | US | disclosed |
| US-9511056-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2016-12-06 | — | — | US | disclosed |
| US-20160225999-A1 | ORGANIC-INORGANIC HYBRID PHOTOELECTRIC CONVERSION DEVICE INCLUDING CONDUCTIVE ORGANIC SEMICONDUCTOR COMPOUND AND METHOD FOR MANUFACTURING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2016-08-04 | — | — | US | disclosed |
| US-20140249074-A1 | ANTIVIRAL COMPOUNDS | GILEAD PHARMASSET LLC (US) | 2014-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029408-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | MAPK1 3854/4885HSD17B10 3314/4885SELE 3219/4885 |
| US-20200361975-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SSB, L1CAM, LEF1 | MAPK1 2325/4885HSD17B10 4570/4885SELE 43/4885 |
| US-11827651-B2 | Organic electroluminescent materials and devices | SSB, L1CAM, LEF1 | MAPK1 2325/4885HSD17B10 4570/4885SELE 43/4885 |
| US-20140249074-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | MAPK1 3854/4885HSD17B10 3314/4885SELE 3219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.